期刊文献+

血管内皮生长因子及其受体与骨肉瘤关系的研究进展 被引量:4

Vascular endothelial growth factor and vascular endothelial growth factor receptor in osteosarcoma
在线阅读 下载PDF
导出
摘要 血管内皮生长因子(VEGF)是一种序列高度保守、高度特异性的促血管内皮细胞生长因子,广泛分布于人和动物体内的大脑、肾脏、肝脏、脾脏、胰腺和骨骼等组织中,对内皮细胞具有强烈的促有丝分裂作用,刺激血管内皮细胞增殖和血管通透性增加,促进新生血管形成。VEGF通过与血管内皮细胞表面受体(VEGFR)特异性结合发挥生物学效应。抑制VEGF及VEGFR的活性可以减缓或阻滞骨肉瘤侵袭和转移。研究表明,VEGF及VEGFR对肿瘤血管及淋巴管的生成及肿瘤侵袭和转移起重要作用。本文对VEGF及VEGFR与骨肉瘤血管与淋巴管生成及其侵袭与转移的关系作一综述。 Vascular endothelial growth factor(VEGF)is a serial factor of the agiogenesis,which is high conservation equence and high degree of specificity.There were universal distribution in cerebrum,kidney,liver,spleen,abdominal salivary gland and skeleton of the human and animals.VEGF promates the vascular endothelial cell mitotic division,stimulus cell multiplication of the vascular endothelial cell and increases vasopermeability,and finally contrubuites the angiogenesis.VEGF specificly binds with vascular endothelial growth factor receport(VEGFR)to deffect the biological effection.In order to slow down or block the invasion and metastatic of osteosarcoma,the activity of VEGF and VEGFR should be inhibited.Studies have shown VEGF and VEGFR play important roles in the invasion and metastatic of tumour.In this paper,we reviewed the role of VEGF and VEGFR in angiogenesis,lymphatic vesselgenesis and invasion metastatic of osteosarcoma.
作者 张先燎 施鑫
出处 《临床肿瘤学杂志》 CAS 2010年第6期567-571,共5页 Chinese Clinical Oncology
基金 全军医学科研"十五"计划杰出人才基金课题资助项目(04J005)
关键词 血管内皮生长因子 血管内皮生长因子受体 骨肉瘤 血管生成 VEGF VEGFR Osteosarcoma Angiogenesis
作者简介 通讯作者,E-mail:Shixi02k@rip.163.com
  • 相关文献

参考文献30

  • 1Ferrar N,Henzel WJ.Pituitary follicularcell secrete anovelheparin-binding growth factorspecific for vascular endothelial cells[J].Biochem Biophys Res Commun,1989,161(2):851.
  • 2Senger DR,Van de Water L,Brown LF,et al.Vascular permeability factor(VPF,VEGF) in tumor biology[J].Cancer Metastasis Rev,1993,12(34):303-324.
  • 3Yancopoulos GD,Duvis S,Gale NW,et al.Vascular specific growth factors and blood vessel formation.[J].Nature,2000,407:242-248.
  • 4艾莉,张小峰,刘鹏,陈磊,胡和平.缺血再灌注损伤促进裸鼠肝癌生长及癌旁组织VEGF和MMP-9表达[J].第二军医大学学报,2008,29(5):495-498. 被引量:3
  • 5Fujimoto J,Toyoki H,Sato E,et al.Clinical implication of expression of vascular endothelial growth factor-Cin metastatic lymph nodes of uterine cervical cancers[J].Br J Cancer,2004,91(3):466-469.
  • 6Boxer GM,Tsiompanou E,Levine T,et al.Immunohistochemical expression of vascular endothelia growth factor and microvesse counting prognostic indicator sinnode-negative colorectal cancer[J].Tumo Biol,2005,26:1-8.
  • 7Otrock ZK,MakaremJA,Shamseddine AI.Vascular endothelial growth factor family of ligands and receptors[J].Blood Cells Mol Dis,2007,38(3):258-268.
  • 8Jia SF,Gua H.VEGF165 is necessary to the metastatic potential of Fas osteosarcoma cells but will not rescue the Fas cells[J].J Exp Ther Oncol,2008,7(2):89-97.
  • 9张海,王志新.VEGF和MMP-9在鼻咽癌中的表达及其与远处转移的关系[J].中国肿瘤临床与康复,2008,15(5):389-393. 被引量:2
  • 10Ochi N,Matsuo Y,Sawai H,et al.Vascular endothelial growth factor2C secreted by pancreatic cancer cell line promotes lymphatic endothelial cellmigration in an in vitromodelof tumor lymphangiogenesis[J].Pancreas,2007,34(4):444-451.

二级参考文献32

  • 1郭翔,曹素梅,洪明晃,张昌卿,韩安家,向燕群,侯景辉,闵华庆.VEGF蛋白检测对预测鼻咽癌远处转移风险的价值[J].癌症,2004,23(10):1171-1175. 被引量:22
  • 2赵佐庆,陈洪茂.肝癌组织和正常肝组织缺血再灌注损伤的比较研究[J].中国普通外科杂志,2005,14(7):497-500. 被引量:7
  • 3钟崇,郭荣平,石明,韦玮,俞武生,李锦清.VEGF与MMP-9在肝癌组织中的表达及其临床意义[J].癌症,2006,25(5):599-603. 被引量:35
  • 4陈星,任虹平,伊铁忠,糜若然,瞿全新,郑曙民,郗颜凤,连进,连争.VEGF-C MMP9及TIMP-1在宫颈癌组织中的表达及临床意义[J].中国肿瘤临床,2007,34(7):381-384. 被引量:9
  • 5Riedel F, Gotte K, Bergler W,et al. Inverse correlation of apoptotic and angiogenic markers in squamous cell carcinoma of the head and neck[ J ]. Oncol Rep,2001,8 ( 3 ) :471-476.
  • 6Li J, Zhang YP, Kirsner RS. Angiogenesis in wound repair:angiogenie growth factors and the extraeeUuiar matrix [ J ]. Mierose Res Tech,2003,60(5) :107-114.
  • 7Sato Y, Abe M,Tanaka K, et al. Signal transduction and transcriptional regulation of angiogenesis [ J ]. Adv Exp Med Biol, 2000, 476(6) :109-115.
  • 8Hee J, Soo KB, Ho Y, et al. Anti-invasive activity of ursoliecid correlates with the reduced expression of matrix metalloproteinase- 9 ( MMP-9 ) in HT-1080 human fibrosarcoma cells [ J ]. Cancer Res, 1996,56 ( 10 ) :2281-2285.
  • 9Horikawa T, Yoshizaki, Sheen TS, et al. Association of Latent membrane protein I and matrix metalloproteinasc 9 with metastasis in nasopharyngeal carcinoma [ J ]. Cancer, 2000,89 ( 4 ) : 715- 723.
  • 10Zucker S, Mirza H, Conner CE, et al. Vascular endothelial growth factor induce tissue factor and matrix metalloproteinase production in endothelial ceils : conversion of prothrombin results in progelatinase a activation and cell proliferation[ J]. Int J Cancer, 1998,75 (5) :780-786.

共引文献36

同被引文献35

  • 1李振波,丘和明.活血化瘀法治疗恶性肿瘤的讨论[J].中国中西医结合杂志,1996,16(9):559-561. 被引量:37
  • 2高保华,王丽娜,李莉,尚红利,郑建云,刘冰.肝癌发生过程中CD31与VEGF的表达[J].现代肿瘤医学,2007,15(8):1135-1137. 被引量:2
  • 3Cooke G, Armstrong ME, Donnelly SC. Macrophage migration inhibitory factor( MIF), enzymatic activity and the inflammatory response [ J ]. Biofactors, 2009, 35 ( 2 ) : 165 - 168.
  • 4Bifulco C, McDaniel K, Leng L, et al. Tumor growth-promoting properties of macrophage migration inhibitory factor [ J J. Curr Pharm Des, 2008, 14(36): 3790-3801.
  • 5Conroy H, Mawhinney L, Donnelly SC. Inflammation and canc- er: macrophage migration inhibitory factor (MIF)--the potential missing link[J]. Quart J Med, 2010, 103 ( 11 ) :831 - 836.
  • 6He XX, Chen K, Yang J, et al. Macrophage migration inhibitory factor promotes eolorectal cancer[J]. Mol Med, 2009, 15 ( 1- 2): 1-10.
  • 7Wang XB, Tian XY, Li Y, et al. Elevated expression of macro- phage migration inhibitory factor correlates with tumor recurrence and poor prognosis of patients with gliomas [ J ]. J Neuroooncol, 2012, 106(1) :43 -51.
  • 8Hira E, Ono T, Dhar DK, et al. Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinoma[ J ]. Cancer, 2005,103 (3) :588 - 598.
  • 9Han I, Lee MR, Nam KW, et al. Expression of macrophage mi- gration inhibitory factor relates to survival in high-grade osteosar- coma[J]. Clin Orthop Relat Res, 2008,466(9) :2107 -2113.
  • 10Cates JM, Friedman DB, Seeley EH, et al. Proteomic analysis of osteogenic sarcoma: association of tumour necrosis factor with poor prognosis[J]. Int J Exp Pathol, 2010, 91 (4) : 335 -349.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部